Structural basis of dimerization of chemokine receptors CCR5 and CXCR4

被引:0
|
作者
Daniele Di Marino
Paolo Conflitti
Stefano Motta
Vittorio Limongelli
机构
[1] Polytechnic University of Marche,Department of Life and Environmental Sciences
[2] Mario Negri Institute for Pharmacological Research-IRCCS, New York
[3] National Biodiversity Future Center (NBFC),Marche Structural Biology Centre (NY
[4] Università della Svizzera italiana (USI),MaSBiC)
[5] Faculty of Biomedical Sciences,Neuronal Death and Neuroprotection Unit, Department of Neuroscience
[6] Euler Institute,Department of Earth and Environmental Sciences
[7] University of Milano-Bicocca,undefined
来源
Nature Communications | / 14卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
G protein-coupled receptors (GPCRs) are prominent drug targets responsible for extracellular-to-intracellular signal transduction. GPCRs can form functional dimers that have been poorly characterized so far. Here, we show the dimerization mechanism of the chemokine receptors CCR5 and CXCR4 by means of an advanced free-energy technique named coarse-grained metadynamics. Our results reproduce binding events between the GPCRs occurring in the minute timescale, revealing a symmetric and an asymmetric dimeric structure for each of the three investigated systems, CCR5/CCR5, CXCR4/CXCR4, and CCR5/CXCR4. The transmembrane helices TM4-TM5 and TM6-TM7 are the preferred binding interfaces for CCR5 and CXCR4, respectively. The identified dimeric states differ in the access to the binding sites of the ligand and G protein, indicating that dimerization may represent a fine allosteric mechanism to regulate receptor activity. Our study offers structural basis for the design of ligands able to modulate the formation of CCR5 and CXCR4 dimers and in turn their activity, with therapeutic potential against HIV, cancer, and immune-inflammatory diseases.
引用
收藏
相关论文
共 50 条
  • [31] CCR5 and CXCR4 antagonist and agonist binding sites
    Martin Teintze
    Royce Wilkinson
    Paul Grieco
    John Mills
    Edward Dratz
    Retrovirology, 3 (Suppl 1)
  • [32] Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5
    Zhang, Hui
    Chen, Kun
    Tan, Qiuxiang
    Shao, Qiang
    Han, Shuo
    Zhang, Chenhui
    Yi, Cuiying
    Chu, Xiaojing
    Zhu, Ya
    Xu, Yechun
    Zhao, Qiang
    Wu, Beili
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [33] Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5
    Hui Zhang
    Kun Chen
    Qiuxiang Tan
    Qiang Shao
    Shuo Han
    Chenhui Zhang
    Cuiying Yi
    Xiaojing Chu
    Ya Zhu
    Yechun Xu
    Qiang Zhao
    Beili Wu
    Nature Communications, 12
  • [34] Therapeutic Perspectives of HIV-Associated Chemokine Receptor (CCR5 and CXCR4) Antagonists in Carcinomas
    Alejandro Gonzalez-Arriagada, Wilfredo
    Garcia, Isaac E.
    Martinez-Flores, Rene
    Morales-Pison, Sebastian
    Coletta, Ricardo D.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [35] Chemokine receptor CCR5 and CXCR4 might influence virus replication during IBDV infection
    Ou, Changbo
    Wang, Qiuxia
    Yu, Yan
    Zhang, Yanhong
    Ma, Jinyou
    Kong, Xianghui
    Liu, Xingyou
    MICROBIAL PATHOGENESIS, 2017, 107 : 122 - 128
  • [36] The development of an europium-GTP assay to quantitate chemokine antagonist interactions for CXCR4 and CCR5
    Labrecque, J
    Anastassov, V
    Lau, GKK
    Darkes, M
    Mosi, R
    Fricker, SP
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2005, 3 (06) : 637 - 648
  • [37] Design and computational support for the binding stability of a new CCR5/CXCR4 dual tropic inhibitor Computational design of a CCR5/CXCR4 drug
    Taylor, Cooper A.
    Miller, Bill R., III
    Parish, Carol A.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2017, 75 : 71 - 79
  • [38] Interferon-γ increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells
    Zella, D
    Barabitskaja, O
    Burns, JM
    Romerio, F
    Dunn, DE
    Revello, MG
    Gerna, G
    Reitz, MS
    Gallo, RC
    Weichold, FF
    BLOOD, 1998, 91 (12) : 4444 - 4450
  • [39] The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease
    Hogaboam, CM
    Carpenter, KJ
    Schuh, JM
    Proudfoot, AAEI
    Bridger, G
    Buckland, KF
    PHARMACOLOGY & THERAPEUTICS, 2005, 107 (03) : 314 - 328
  • [40] In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4
    Higuita, Edwin A.
    Jaimes, Fabian A.
    Rugeles, Maria T.
    Montoya, Carlos J.
    AIDS RESEARCH AND THERAPY, 2013, 10